Beta-Caryophyllene

N/A

Report date: 2022/12/04 16:30:20

Base Information

Drug NameBeta-Caryophyllene
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHartford Hospital
China Registration ClassN/A

Develop Information

Active CompaniesHartford Hospital
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A